Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis

American Journal of Transplantation

Volumn 11, Issue 4, 2011, Pages 775-785

  Basha, H I ^a   Subramanian, V ^a   Seetharam, A ^a   Nath, D S ^a   Ramachandran, S ^a   Anderson, C D ^a   Shenoy, S ^a   Chapman, W C ^a   Crippin, J S ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; T cell; transplantation; viral

Indexed keywords

CYCLOSPORIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER ALLOGRAFT FIBROSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; TH17 CELL;

CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; RECURRENCE; TH17 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79953244924     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03458.x     Document Type: Article

References (37)

1. Wright TL, Donegan E, Hsu HH, et al,. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317-322.
2. Berenguer M, Lopez-Labrador FX, Wright TL,. Hepatitis C and liver transplantation. J Hepatol 2001; 35: 666-678. (Pubitemid 33078280)
3. Ferrari C, Valli A, Galati L, et al,. T cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286-295. (Pubitemid 24046771)
4. Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T,. Lack of optimal T cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol 2003; 64: 224-230. (Pubitemid 36197350)
5. Chang KM, Thimme R, Melpolder JJ, et al,. Differential CD4(+) and CD8(+) T cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33: 267-276. (Pubitemid 32016910)
6. Wedemeyer H, He XS, Nascimbeni M, et al,. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002; 169: 3447-3458. (Pubitemid 35013196)
7. Gruener NH, Lechner F, Jung MC, et al,. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001; 75: 5550-5558. (Pubitemid 32488148)
8. Lucas M, Ulsenheimer A, Pfafferot K, et al,. Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PLoS One 2007; 2: e649.
9. Semmo N, Klenerman P,. CD4+ T cell responses in hepatitis C virus infection. World J Gastroenterol 2007; 13: 4831-4838. (Pubitemid 47496748)
10. Freeman AJ, Marinos G, Ffrench RA, Lloyd AR,. Immunopathogenesis of hepatitis C virus infection. Immunol Cell Biol 2001; 79: 515-536. (Pubitemid 33070441)
11. Hassoba H, Leheta O, Sayed A, et al,. IL-10 and IL-12p40 in Egyptian patients with HCV-related chronic liver disease. Egypt J Immunol 2003; 10: 1-8.
12. Sobue S, Nomura T, Ishikawa T, et al,. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J Gastroenterol 2001; 36: 544-551. (Pubitemid 32791841)
13. Bharat A, Barros F, Narayanan K, et al,. Characterization of virus-specific T cell immunity in liver allograft recipients with HCV-induced cirrhosis. Am J Transplant 2008; 8: 1214-1220. (Pubitemid 351763698)
14. Lemmers A, Moreno C, Gustot T, et al,. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49: 646-657.
15. Zhang JY, Zhang Z, Lin F, et al,. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91.
16. Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y,. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol 2009; 157: 261-270.
17. Radstake TR, van Bon L, Broen J, et al,. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 2009; 4: e5903.
18. Shen W, Durum SK,. Synergy of IL-23 and Th17 cytokines: New light on inflammatory bowel disease. Neurochem Res 2010; 35: 940-946.
19. Fabrega E, Lopez-Hoyos M, San Segundo D, Casafont F, Pons-Romero F,. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl 2009; 15: 629-633.
20. Miossec P, Korn T, Kuchroo VK,. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898.
21. Feng W, Li W, Liu W, Wang F, Li Y, Yan W,. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp Mol Pathol 2009; 87: 212-218.
22. Antonelli A, Ferri C, Ferrari SM, et al,. High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia. Clin Rheumatol 2009; 28: 1179-1185.
23. Huang YS, Hwang SJ, Chan CY, et al,. Serum levels of cytokines in hepatitis C-related liver disease: A longitudinal study. Zhonghua Yi Xue Za Zhi (Taipei) 1999; 62: 327-333.
24. Oyanagi Y, Takahashi T, Matsui S, et al,. Enhanced expression of interleukin-6 in chronic hepatitis C. Liver 1999; 19: 464-472. (Pubitemid 30019059)
25. Ali MA, Koura BA, el-Mashad N, Zaghloul MH,. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma. Egypt J Immunol 2004; 11: 83-90.
26. Bortolami M, Kotsafti A, Cardin R, Farinati F,. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease. J Viral Hepat 2008; 15: 515-522. (Pubitemid 351798989)
27. Ayyoub M, Deknuydt F, Raimbaud I, et al,. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A 2009; 106: 8635-8640.
28. Gruener NH, Jung MC, Schirren CA,. Recurrent hepatitis C virus infection after liver transplantation: Natural course, therapeutic approach and possible mechanisms of viral control. J Antimicrob Chemother 2004; 54: 17-20. (Pubitemid 39036122)
29. Forman LM,. To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis 2003; 7: 615-629. (Pubitemid 37093422)
30. Piazzolla G, Tortorella C, Schiraldi O, Antonaci S,. Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha. J Clin Immunol 2000; 20: 54-61. (Pubitemid 30210107)
31. Barrett L, Gallant, M,., Howley C, Bowmer MI, Hirsch G, Peltekian K,. Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals. BMC Immunol 2008; 28: 1-16.
32. Bolacchi F, Sinistro A, Ciaprini C, et al,. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006; 144: 188-196.
33. Manigold T, Shin EC, Mizukoshi E, et al,. Foxp3+CD4+CD25 +T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 2006; 107: 4424-4432. (Pubitemid 43801369)
34. Demirkiran A, Baan CC, Kok A, Metcelaar HJ, Tilanus HW, van der Laan LJ,. Intrahepatic detection of FOXP3 gene expression after liver transplantation using minimally invasive aspiration biopsy. Transplantation 2007; 83: 819-823. (Pubitemid 46569203)
35. Rutitzky LI, Smith PM, Stadecker MJ,. T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation. Eur J Immunol 2009; 39: 2470-2481.
36. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, et al,. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008; 205: 3133-3144.
37. Morsy MA, Norman PJ, Mitry R, Rela M, Heaton ND, Vaughan RW,. Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique. Lab Invest 2005; 85: 285-296. (Pubitemid 40208932)